Header graphic for print
Focus on Regulation

Tag Archives: drug evaluation

EMA seeks to support the use of patient registries and to improve dialogue between various stakeholders

  In September 2015, the European Medicines Agency (EMA) launched the initiative for patient registries. The purpose of the initiative is to improve the benefit-risk evaluation of medicinal products for human use. The EMA’s initiative for patient registries focuses mainly on the ways in which existing patient registries could be improved. This could be systematically considered